Fulcrum Therapeutics (FULC) Change in Receivables (2020 - 2025)
Fulcrum Therapeutics (FULC) has disclosed Change in Receivables for 6 consecutive years, with -$979000.0 as the latest value for Q2 2025.
- Quarterly Change in Receivables fell 141.96% to -$979000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Dec 2025, down 234.45% year-over-year, with the annual reading at -$2.1 million for FY2025, 234.45% down from the prior year.
- Change in Receivables for Q2 2025 was -$979000.0 at Fulcrum Therapeutics, up from -$1.1 million in the prior quarter.
- The five-year high for Change in Receivables was $2.3 million in Q2 2024, with the low at -$5.0 million in Q4 2022.
- Average Change in Receivables over 5 years is -$123833.3, with a median of -$21000.0 recorded in 2021.
- Peak annual rise in Change in Receivables hit 33400.0% in 2022, while the deepest fall reached 3540.15% in 2022.
- Over 5 years, Change in Receivables stood at -$137000.0 in 2021, then tumbled by 3540.15% to -$5.0 million in 2022, then skyrocketed by 99.14% to -$43000.0 in 2023, then crashed by 3527.91% to -$1.6 million in 2024, then surged by 37.24% to -$979000.0 in 2025.
- According to Business Quant data, Change in Receivables over the past three periods came in at -$979000.0, -$1.1 million, and -$1.6 million for Q2 2025, Q1 2025, and Q4 2024 respectively.